Validation of lymphocyte to monocyte ratio in resected small bowel adenocarcinoma as a predictor of survival. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does ...

Within the development set, 68 advanced-line patients were used as well ... CB, clinical benefit; ICI, immune checkpoint inhibitor; NSCLC, non–small cell lung cancer. From PROPHETIC, 500 patients with ...

Drusen is believed to damage RPE cells and contribute to their eventual loss and subsequent loss of photoreceptors. These data add to our growing understanding of zervimesine’s mechanism and its ...

The cell lines are stated to be high-value solutions for the recombinant adeno-associated viruses (rAAV) manufacturing, for cell and gene therapy use. Credit: totojang1977 / Shutterstock. Swiss ...

Dr. Desai is the founder of Eyestem Research, a biotechnology company developing scalable cell replacement therapies, based in Karnataka, India. "We have a first-in-human trial ongoing for [retinal ...

“The interim clinical data reinforces the potential of our RPESC-RPE-4W cell therapy to restore vision and potentially alter the course of dry AMD. These findings represent an important step toward ...

Figure 5. The relative expression of EMT-related genes in RPE cells treated with MTX (100 μg/mL), DEXA (50 μg/mL), and combination of MTX + DEXA. The dashed line represents the mRNA level in the ...

We note that the impact of adding Spytag-ICAM-1 on T cell activation is largely absent on the parental CHO-K1 cell line prior to hamster ICAM-1 knockout (Figure EV2). This underlines the importance of ...

The early mammalian embryo and cell lines derived from it are characterized by distinct metabolic states that have long been assumed to be a byproduct of differentiation, and together they represent ...